Many of our experienced and dedicated physicians have published various materials - several of which are presented here.
 

Physician Publications

  • Klebanoff CA, Gattinoni L, Palmer DC, Muranski P, Ji Y, Hinrichs CS, Borman ZA, Kerkar SP, Scott CD, Finkelstein S, Rosenberg SA, Restifo NP.  Determinants of successful CD8+ T cell adoptive immunotherapy for large established tumors in mice. Clin Cancer Res July 7, 2011 Epub 2011 July 7

 

  • Kang J, Chen M-H, Zhang Y, Moran BJ, Dosoretz DE, Katin MJ, Braccioforte MH,  Salenius SA, D’Amico AV.  The type of Diabetes Mellitus and the odds of Gleason score 8 to 10 prostate cancer.  In press, Int J Rad Oncol Biol Phys 2011

 

  • Nguyen PL, Chen MH, Beckman JA, Beard CJ, Martin NE, Choueiri TK, Hu JC, Hoffman KE, Dosoretz DE, Moran BJ, Salenius SA, Braccioforte MH, Kantoff PW, D'Amico AV, Ennis RD.  Adverse Impact of Androgen Deprivation Therapy on All-cause Mortality in Men with High-risk Prostate Cancer and a History of Congestive Heart Failure (CHF) or Myocardial Infarction (MI). In press, Int J Rad Oncol Biol Phys 2011

 

  • Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D'Amico AV.  Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation.  Cancer. 2011 Jan 15;117(2):406-13.  Epub 2010 Aug 31.

 

  • Granai CO and Orr JW . Improving breast care: providing, guiding, expertise, and leadership. Clin Obstet Gynecol 2011; 54(1): 85-90.

 

  • Orr, JW and Moore RG. Foreword. Clin Obstet Gynecol 2011; 54(1): 83-84.

 

  • Smith W, Salenius S, Cobb C, Marzan R, Sabina S, Beccaria L, Sitton-Petro T, Werner DL, Kamm M, Lenz S, Taylor T.  A Survey of Clinical Research Coordinators in the Cooperative Group Setting of the American College of Radiology Imaging Network (ACRIN). Academic Radiology 2010; November 17(11):1449-1454

 

  • Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, Cher ML, Andic F, Rossi PJ, Kucuk O. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer. 2010; Oct;62(7):996-1000.
  • Hendee WR, Becker GJ, Borgstede JP, Bosma J, Casarella WJ, Erickson BA, Maynard CD, Thrall JH, Wallner PE.   Addressing overutilization in medical imaging. Radiology. 2010; Oct;257(1):240-5.
  • Holloway RW, Grendys EC, Lefebvre P, Vekeman F, McMeekin S. Tolerability, efficacy, and safety of pegylated liposomal Doxorubicin in combination with Carboplatin versus gemcitabine-Carboplatin for the treatment of platinum-sensitive recurrent ovarian cancer: a systematic review. Oncologist 2010;15(10):1073-82
  • Allison RR, Sibata CH. Photodynamic therapy: mechanism of action and role in the treatment of skin disease. G Ital Dermatol Venereol. 2010; Aug;145(4):491-507. 
  • Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010; Jul 29;363(5):411-22.
  • Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tomé W, Harris E, Price RA, Konski AA, Wallner PE.  Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: Report of the ASTRO Emerging Technology Committee.  Int J Radiat Oncol Biol Phys 2010;8(1):3-10.
  • Sandler HM, Liu PY, Dunn RL, Khan DC, Tropper SE, Sanda MG, Mantz CA. Reduction in patient-reported acute morbidity in prostate cancer patients treated with 81-Gy Intensity-modulated radiotherapy using reduced planning target volume margins and electromagnetic tracking: assessing the impact of margin reduction study. Urology 2010;75(5):1004-8.
  • Quaranta BP, Das SK, Shafman TD, Light KL, Marks LB. The utility of non-axial treatment beam orientations for lower lobe lung cancers. J Appl Clin Med Phys 2010;11(1):2010.
  • Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV. Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2010;76(5):1439-44.
  • Allison RR, Sheng C, Cuenca R, Bagnato VS, Austerlitz C, Sibata CH. Photodynamic therapy for anal cancer. Photodiagnosis Photodyn Ther. 2010 Jun;7(2):115-9.
  • Nguyen PL, Chen MH, Choueiri TK, Hoffman KE, Hu JC, Martin NE, Beard CJ, Dosoretz DE, Moran BJ, Katin MJ, Braccioforte MH, Ross R, Salenius SA, Kantoff PW, D'Amico AV. Risk of All-Cause and Prostate Cancer-Specific Mortality After Brachytherapy in Men with Small Prostate Size. Int J Radiat Oncol Biol Phys. 2010 Jun 2. [Epub ahead of print]  
  • Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV. Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy. Int J Radiat Oncol Biol Phys 2010;77(1):147-52.
  • Lee TK, O'Brien KF, Wang W, Johnke RM, Sheng C, Benhabib SM, Wang T, Allison RR. Radioprotective effect of American ginseng on human lymphocytes at 90 minutes postirradiation: a study of 40 cases. J Altern Complement Med. 2010 May;16(5):561-7.  
  • Hoffman KE, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin MJ, Ross R, D'Amico AV. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer. Cancer 2010;116(11):2590-5.
  • Zhu D, Austerlitz C, Benhabib S, Mota H, Allison RR, Campos D. Study of a spherical phantom for Gamma knife dosimetry. J Appl Clin Med Phys. 2010 Apr 17;11(2):3130.
  • Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, Pouliot J, Konski AA, Wallner PE.  American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.  Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):963-72. 
  • Hayes JH, Chen MH, Moran BJ, Braccioforte MH, Dosoretz DE, Salenius S, Katin MJ, Ross R, Choueiri TK, D'Amico AV. Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke. BJU Int 2010; 106(7):797-85.
  • Dosoretz AM, Chen MH, Salenius SA, Ross RH, Dosoretz DE, Katin MJ, Mantz C, Nakfoor BM, D'Amico AV. Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy. Cancer 2010;116(4):837-42.
  • Cheung AK, Chen MH, Moran BJ, Braccioforte MH, Dosoretz DE, Salenius S, Katin M, Ross R, D'Amico AV. The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after 1999. American Brachytherapy Society Guideline statement. Brachytherapy 2010;9(2):145-50.
  • Weinberg BD, Allison RR, Sibata C, Parent T, Downie G. Results of combined photodynamic therapy (PDT) and high dose rate brachytherapy (HDR) in treatment of obstructive endobronchial non-small cell lung cancer (NSCLC). Photodiagnosis Photodyn Ther. 2010 Mar;7(1):50-8.
  • Buyyounouski MK, Price RA, Jr., Harris EE, Miller R, Tome W, Schefter T, Parsai EI, Konski AA, Wallner PE. Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. Int J Radiat Oncol Biol Phys 2010;76(5):1297-304.
  • Allison RR, Sibata CH. Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn Ther 2010;7(2):61-75.
  • Allison RR, Bagnato VS, Sibata CH. Future of oncologic photodynamic therapy. Future Oncol 2010;6(6):929-40.
  • Karvinen KH, Dubose KD, Carney B, Allison RR.  Promotion of physical activity among Oncologists in the United States.  J Support oncol.  2010 Jan-Feb;8(1):35-41. 
  • Shridhar R, Bolton S, Joiner MC, Forman JD. Dose escalation using a hypofractionated, intensity-modulated radiation therapy boost for localized prostate cancer: preliminary results addressing concerns of high or low alpha/beta ratio. Clin Genitourin Cancer 2009;7(3):E52-7.
  • Ritter M, Forman J, Kupelian P, Lawton C, Petereit D. Hypofractionation for prostate cancer. Cancer J 2009;15(1):1-6.
  • Prosnitz LR, Horton J, Wallner PE. Accelerated partial breast irradiation: caution and concern from an ASTRO task force. Int J Radiat Oncol Biol Phys 2009;74(4):981-4.
  • Hahn CA, Zhou SM, Raynor R, Tisch A, Light K, Shafman T, Wong T, Kirkpatrick J, Turkington T, Hollis D, Marks LB. Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction. Int J Radiat Oncol Biol Phys 2009;73(4):1082-7.
  • Soubani AO, Forman JD. An unusual cause of increased abdominal girth. QJM. 2009 Apr;102(4):289.  
  • D'Amico AV, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, Chen MH. Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease. J Clin Oncol 2009;27(24):3923-8.
  • Youssef A, Tawadrous W. Does Intraprostatic Calcifications Affect Low-Dose-Rate Brachytherapy? Brachytherapy 2008;7(2):184-5.
  • Wallner PE, Konski A. The impact of technology on health care cost and policy development. Semin Radiat Oncol 2008;18(3):194-200.

·Onik G, Barzell W.  Transperineal 3D mapping biopsy of theprostate: an essential tool in selecting patients for focal prostate cancertherapy.  Urol Oncol. 2008Sep-Oct;26(5):506-10.  

 

  • Wallner PE, Konski A. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development. J Am Coll Radiol 2008;5(11):1125-9.
  • Trabulsi EJ, Valicenti RK, Hanlon AL, Pisansky TM, Sandler HM, Kuban DA, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Lin DW, Anscher MS, Slawin KM, Roehrborn CG, Forman JD, Liauw SL, Kestin LL, DeWeese TL, Scardino PT, Stephenson AJ, Pollack A. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology 2008;72(6):1298-302; discussion 302-4.
  • Swanson GP, Goldman B, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED. The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794. J Urol 2008;180(6):2453-7; discussion 8.
  • Steinberg ML. Inequity in cancer care: explanations and solutions for disparity. Semin Radiat Oncol 2008;18(3):161-7.
  • Orr JW, Jr., Taylor PT, Jr. Surgical management of endometrial cancer: how much is enough? Gynecol Oncol 2008;109(1):1-3.
  • Orr JW, Jr., Naumann WR, Escobar P. "Attitude is a little thing that makes a big difference" Winston Churchill. Gynecol Oncol 2008;109(1):147-51; author reply 51-3.
  • Orr JW, Kelley J, Dizon D, Escobar P, Fleming E, Gemignani M, Hetzel D, Hoskins W, Kieback D, Kilgore LC, LaPolla J, Lewin S, Lucci J, Markman M, Pothuri B, Powell C, Tejada-Berges T. Society of Gynecologic Oncologists Position Paper: Breast Cancer Care. Gynecol Oncol 2008;110:7-12.
  • Escobar PF, Orr JW, Jr., Grendys EC, Roland PY. Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40. Int J Gynecol Cancer 2008;18(4):876-7.
  • Escobar PF, Howard JL, Kelly J, Roland PY, Grendys EC, Dosoretz DE, Orr JW, Jr. Ureteroarterial fistulas after radical pelvic surgery: pathogenesis, diagnosis, and therapeutic modalities. Int J Gynecol Cancer 2008;18(4):862-7.
  • Escobar P, Orr JW. The Human Papillomavirus Vaccine: Current Status. The Female Patient 2008;33(1-4).
  • D'Ambrosio DJ, Pollack A, Harris EE, Price RA, Jr., Verhey LJ, Roach M, 3rd, Demanes DJ, Steinberg ML, Potters L, Wallner PE, Konski A. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2008;70(3):671-7.
  • Abushahin F, Singh DK, Lurain JR, Grendys EC, Rademaker AW, Schink JC. Weekly topotecan for recurrent platinum resistant ovarian cancer. Gynecol Oncol 2008;108(1):53-7.
  • Barzell WE, Melamed MR.  Appropriate Patient Selection in the focal Treatment of Prostate Cancer: The Role of Transperineal 3-Dimensional Pathologic Mapping of the Prostate – A 4-Year Experience.  Urology. 2007 Dec;70(6 Suppl):27-35. 

·Bostwick DG, Waters DJ, FarleyER, Meiers I, Rukstalis D, Cavanaugh WA, Ragde H, Dineen MK, Bahn D, Scionti S,Babian R, Ellis DS, Rewcastle JC, Burke HB, Andriole GL, Onik G, Barqawi AE,Maksem J, Barzell WE. Group consensus reports from the ConsensusConference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24,2006.  Urology. 2007 Dec;70(6Suppl):42-4.  

 

  • Wojcicka J, Yankelevich R, Iorio S, Tinger A. On-Board Imager-based MammoSite treatment verification. Med Biol Eng Comput 2007;45(11):1065-9.
  • Northouse LL, Mood DW, Schafenacker A, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Kershaw T. Randomized clinical trial of a family  intervention for prostate cancer patients and their spouses. Cancer. 2007 Dec 15;110(12):2809-18.  

 

  • Wallner PE, Konski A. Significance of End-Point Selection in the Assessment of Emerging Technologies. Oncology 2007;21(5 Supp. 2):32.
  • Hemrajani RH, Kim KB, Amos WR, Mann DE. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence. Melanoma Res 2007;17(4):257-9.
  • Vaishampayan U, Hussain M, Banerjee M, Seren S, Sarkar FH, Fontana J, Forman JD, Cher ML, Powell I, Pontes JE, Kucuk O. Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer. 2007;59(1):1-7.  
  • Grendys EC. Pregnancy and Neoplastic Disease. In: Goldman L, Bennett JC, eds. Cecil's Textbook of Medicine. 23rd ed. Philadelphia: WB Saunders; 2007.
  • Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007;67(3):709-19.
  • Farr JB, Maughan RL, Yudelev M, Blosser E, Brandon J, Horste T, Forman JD.  Radiologic validation of a fast neutron multileaf collimator. Med Phys. 2007 Sep;34(9):3475-84. 
  • Santanam L, He T, Yudelev M, Forman JD, Orton CG, Heuvel FV, Maughan RL, Burmeister J. Intensity modulated neutron radiotherapy for the treatment of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1546-56.  
  • Northouse LL, Mood DW, Montie JE, Sandler HM, Forman JD, Hussain M, Pienta KJ, Smith DC, Sanda MG, Kershaw T. Living with prostate cancer: patients' and spouses' psychosocial status and quality of life. J Clin Oncol. 2007 Sep 20;25(27):4171-7.
  • Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I; American Urological Association Prostate Cancer Guideline Update Panel. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007 Aug;178(2):597-601.  
  • Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED; SWOG 8794. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol. 2007 Jun 1;25(16):2225-9.  
  • Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL,  Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007 May 20;25(15):2035-41.
  • Wallner PE. "Naked" radiopharmaceuticals. Int J Radiat Oncol Biol Phys 2006;66(2 Suppl):S60-1.
  • Steinberg ML, Fremont A, Khan DC, Huang D, Knapp H, Karaman D, Forge N, Andre K, Chaiken LM, Streeter OE, Jr. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges. Cancer 2006;107(11):2669-77.
  • Shafman TD. Combination chemotherapy and radiation therapy for upper aerodigestive tract cancers. Med Health R I 2006;89(2):55-8.
  • Rubenstein JH. Spare the heart: how much effort should we expend to assure cardiac tissue is not needlessly irradiated? Am J Clin Oncol 2006;29(3):217-8.
  • Raj KA, Evans ES, Prosnitz RG, Quaranta BP, Hardenbergh PH, Hollis DR, Light KL, Marks LB. Is there an increased risk of local recurrence under the heart block in patients with left-sided breast cancer? Cancer J 2006;12(4):309-17.
  • Quaranta BP, Black Q. HDR Brachytherapy: From Concept to Clinic. Advances for Imaging & Oncology Administrators 2006;16(10).
  • Orr JW, Jr., Dosoretz DD, Mahoney D, Roland PY, Kelly FJ, Blitzer P, Nakfoor B, Katin M, Rubenstein J, Boothby RR. Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-HDRT): technique and outcome. Gynecol Oncol 2006;100(1):145-8.
  • Long HJ, 3rd, Monk BJ, Huang HQ, Grendys EC, Jr., McMeekin DS, Sorosky J, Miller DS, Eaton LA, Fiorica JV. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 2006;100(3):537-43.
  • Cardosi RJ, Drake J, Holmes S, Tebes SJ, Hoffman MS, Fiorica JV, Roberts WS, Grendys EC, Jr. Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat. Am J Obstet Gynecol 2006;195(2):607-14; discussion 14-6.